Improved High Concentration Anti-Tnfalpha Antibody Liquid Formulations

Patent No. EP2637690 (titled "Improved High Concentration Anti-Tnfalpha Antibody Liquid Formulations") was filed by Abbvie Biotechnology on Nov 11, 2011. The application was issued on Sep 21, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ARNOLD & SIEDSMAJun 21, 2017PRINS
GENERICS UK TRADING MYLANJun 21, 2017POHLMAN
HOFFMANN EITLEJun 21, 2017-
DEHMEL & BETTENHAUSENJun 20, 2017RUCKERL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2637690

ABBVIE BIOTECHNOLOGY
Application Number
EP11839071A
Filing Date
Nov 11, 2011
Status
Revoked
Mar 2, 2018
Publication Date
Sep 21, 2016